Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Antithrombin

recombinant human antithrombin III
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Antithrombin, covering 2015-07-15 to 2017-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia [Phase 3]

See pricing